Zheng Weihong is the founder of Trinomab. Backed by Gree Gold Investment, Xicheng Jinrui, Efung Capital. Based in Zhuhai, China.
Zheng Weihong is the Co-founder, CEO, and President of Trinomab, a clinical-stage biopharmaceutical company focused on the R&D of innovative fully native human mAb drugs. The company utilizes its fourth-generation fully human antibody technology, HitmAb®, to develop new natural human monoclonal antibodies against infectious diseases and cancers.
Full founder directory · Investor directory · Company funding database · Fundraising library